サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1322030

心臓再同期療法 (CRT) の世界市場 (2023-2030年)：タイプ・用途 (心室内非同期・心室間非同期)・エンドユーザー別の規模・シェア・成長分析・予測

Global Cardiac Resynchronization Therapy Market Size, Share, Growth Analysis, By Type, By Application(Intraventricular desynchrony, Interventricular desynchrony), By End User - Industry Forecast 2023-2030
出版日: | 発行: SkyQuest | ページ情報: 英文 242 Pages | 納期: 3～5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
心臓再同期療法 (CRT) の世界市場 (2023-2030年)：タイプ・用途 (心室内非同期・心室間非同期)・エンドユーザー別の規模・シェア・成長分析・予測
出版日: 2023年07月12日
発行: SkyQuest
ページ情報: 英文 242 Pages
納期: 3～5営業日
  • 全表示
  • 概要
  • 目次
概要

世界の心臓再同期療法 (CRT) の市場規模は、2021年の40億6,000万米ドル、2022年の42億6,000万米ドルから、予測期間中は4.8%のCAGRで推移し、2030年には62億3,000万米ドルの規模に成長すると予測されています。

CRTは心不全患者の治療法です。世界のCRT市場は、世界の心血管疾患の有病率の上昇により大きな成長を遂げています。CRTデバイスは、同期した心臓収縮を回復させ、心機能と生活の質を改善するのに役立ちます。技術の進歩、認知度の向上、高齢者人口の増加などの要因が市場拡大の原動力となっています。さらに、有利な償還政策や継続的なR&D活動も今後数年の市場成長をさらに促進すると予想されています。

予防と治療の進歩にもかかわらず、心血管疾患による死亡の約50％は心臓突然死によるものです。これは依然として重大な死亡原因です。心臓病とその危険因子の有病率は増加しており、CRTデバイスへの需要が高まっています。

当レポートでは、世界の心臓再同期療法 (CRT) の市場を調査し、市場概要、市場への各種影響因子の分析、技術・イノベーションの動向、法規制環境、市場規模の推移・予測、各種区分・地域別の内訳、競合情勢、主要企業のプロファイルなどをまとめています。

目次

  • エグゼクティブサマリー
  • 調査手法
  • 親市場の分析
  • 市場概要
  • 市場規模
  • 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
  • 主要市場洞察
    • 技術分析
    • 価格分析
    • サプライチェーン分析
    • バリューチェーン分析
    • 市場のエコシステム
    • IP分析
    • 貿易分析
    • スタートアップ分析
    • 原材料分析
    • イノベーションマトリックス
    • パイプライン製品の分析
    • マクロ経済指標
    • 主要投資分析
    • 主要成功要因
    • 競合の程度
  • 市場力学と見通し
    • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題
  • 規制状況
  • ポーターの分析
  • 将来のディスラプションに関するSkyquestの特別な洞察
  • 世界の心臓再同期療法 (CRT) 市場：タイプ別
    • 市場概要
    • CRT除細動器 (CRT-D)
    • CRTペースメーカー
  • 世界の心臓再同期療法 (CRT) 市場：用途別
    • 市場概要
    • 心室内非同期
    • 心室間 (VV) 非同期
    • 房室 (AV) 非同期
  • 世界の心臓再同期療法 (CRT) 市場：エンドユーザー別
    • 市場概要
    • 病院
    • 心臓ケアセンター
    • 外来手術センター
  • 世界の心臓再同期療法 (CRT) 市場：地域別
    • 市場概要
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 競合情勢
  • トップ5社の比較
  • 主要企業の市場での位置付け
  • 主要企業の採用戦略
  • 主要成功戦略
  • 市場における最近の活動
  • 主要企業の市場シェア
  • 主要企業プロファイル
    • Medtronic
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Biotronik SE & Co. KG
    • LivaNova PLC
    • St. Jude Medical, Inc.
    • EBR Systems, Inc.
    • Cardiac Dimensions, Inc.
    • Sorin Group
    • Cook Medical, Inc.
    • Osprey Medical, Inc.
    • BioVentrix, Inc.
    • MicroPort Scientific Corporation
    • Endologix, Inc.
    • InspireMD, Inc.
    • Integer Holdings Corporation
    • Inari Medical, Inc.
    • Syncardia Systems, Inc.
    • AngioDynamics, Inc.
    • Cardiva Medical, Inc.
目次
Product Code: SQMIG35D2074

Global Cardiac Resynchronization Therapy Market size was valued at USD 4.06 billion in 2021 and is poised to grow from USD 4.26 billion in 2022 to USD 6.23 billion by 2030, growing at a CAGR of 4.8% in the forecast period (2023-2030).

Cardiac resynchronization therapy (CRT) is a treatment for heart failure patients. The global market for CRT is witnessing significant growth due to the rising prevalence of cardiovascular diseases worldwide. CRT devices help restore synchronized heart contractions, improving cardiac function and quality of life. Factors such as technological advancements, increasing awareness, and the growing geriatric population are driving market expansion. Moreover, favorable reimbursement policies and ongoing research and development activities are expected to further fuel the market's growth in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of Cardiac Resynchronization Therapy and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report:

Global Cardiac Resynchronization Therapy Market is segmented based on the Type, Application, End User and region. Based on Type Global market is segmented into CRT-Defibrillator and CRT-Pacemaker. Based on the Application into Intraventricular desynchrony, Interventricular (V-V) desynchrony, Atrioventricular (A-V) desynchrony. Based on the End User into Hospitals, Cardiac Care Centres, and Ambulatory Surgical Centres. Based on region, it is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.

Driver

Despite advancements in prevention and therapy, approximately 50% of deaths caused by cardiovascular diseases are due to sudden cardiac death. This remains a significant cause of mortality. The prevalence of heart diseases and their risk factors is increasing, leading to a higher demand for cardiac resynchronization therapy devices. Heart failure is one of the primary contributors to global mortality.

Restrain

In June 2022, Boston Scientific Corporation initiated a recall for the INGENIO family of pacemakers and CRT-Ps. Some of the affected devices include ADVANTIO DR EL, INGENIO DR EL, and VITALIO DR EL. These devices were distributed between November 2016 and August 2022, after being manufactured from September 2016 to December 2018. Approximately 48,000 devices were recalled in the United States due to the potential safety mode activation.

Trend

Patients with heart failure who are at a high risk of sudden cardiac death should consider using CRT-Defibrillators (CRT-D). A CRT-D device treats slow heart rhythms like a regular pacemaker, but it also delivers small electrical impulses to the left and right ventricles to facilitate synchronized contractions. This improves the efficiency of heart pumping. Furthermore, CRT-D devices can address arrhythmias, which are rapid and dangerous heartbeats that may lead to sudden cardiac arrest. If the device detects such rapid heartbeats, it delivers a shock to the heart, known as defibrillation, to restore a regular rhythm. Without this life-saving treatment, the rapid pulse can result in death within minutes. These devices offer new opportunities for patient engagement and remote monitoring through smartphone connectivity and connected applications. They are favored by patients due to their user-friendly design, longer battery life, and compatibility with MRI scans. Given the increasing incidence and mortality of cardiovascular diseases, the demand for these devices has recently risen.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Cardiac Resynchronization Therapy Market by Type

  • Market Overview
  • CRT-Defibrillator and CRT-Pacemaker

Global Cardiac Resynchronization Therapy Market by Application

  • Market Overview
  • Intraventricular desynchrony
  • Interventricular (V-V) desynchrony
  • Atrioventricular (A-V) desynchrony

Global Cardiac Resynchronization Therapy Market by End User

  • Market Overview
  • Hospitals
  • Cardiac Care Centres
  • and Ambulatory Surgical Centres

Global Cardiac Resynchronization Therapy Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Medtronic
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biotronik SE & Co. KG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LivaNova PLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • St. Jude Medical, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • EBR Systems, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardiac Dimensions, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sorin Group
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cook Medical, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Osprey Medical, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioVentrix, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MicroPort Scientific Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Endologix, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • InspireMD, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Integer Holdings Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Inari Medical, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Syncardia Systems, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AngioDynamics, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardiva Medical, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments